Saturday 17 October 2026
Export CBT’s income statement to Excel — free account
Cabot Corporation
CBT Basic Materials Specialty Chemicals
Cabot Corporation’s revenue for fiscal 2025 (year ended September 2025) was $3.7 billion, down 7.04% from fiscal 2024. In the quarter to June 2026, revenue grew 6.39%, EPS fell 93.6%, free cash flow fell 77.0% and total debt rose 4.77%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.
74.29
1.19
−1.58%
Follow CBT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
12.55 | 11.53 | 14.18 | 25.51 |
P/S ratio |
1.10 | 0.97 | 1.10 | 1.29 | |
P/FCF ratio |
10.44 | 8.71 | 9.07 | 15.22 | |
P/Operating CF |
18.65 | 27.72 | 50.86 | 62.48 | |
P/B ratio |
2.40 | 2.02 | 2.32 | 2.70 | |
Price to Tangible BV |
2.69 | 2.27 | 2.61 | 3.03 | |
EV/Sales |
1.33 | 1.22 | 1.39 | 1.57 | |
EV/EBITDA |
6.39 | 5.83 | 6.79 | 8.48 | |
EV/Operating CF |
7.45 | 6.58 | 7.40 | 11.49 | |
EV/FCF |
12.67 | 10.95 | 11.49 | 18.54 | |
Quick Ratio |
0.97 | 0.97 | 0.85 | 0.86 | |
Current Ratio |
1.61 | 1.67 | 1.45 | 1.47 | |
Net Debt/EBITDA |
4.93 | 5.27 | 5.88 | 6.91 | |
Debt/Assets |
29.62% | 29.97% | 33.33% | 32.03% | |
Debt/Equity |
0.66 | 0.65 | 0.77 | 0.73 | |
Asset Turnover |
0.98 | 0.98 | 0.93 | 0.93 | |
Operating CF/Net income |
4.76 | 1.73 | 1.15 | 12.50 | |
Capex/Depreciation |
(0.92) | (1.68) | (0.92) | (0.76) | |
Interest Coverage |
6.85 | 7.17 | 7.17 | 5.44 | |
Research and Development Expense of Revenue |
1.67% | 1.53% | 1.55% | 1.32% | |
Selling, General and Administrative Expense of Revenue |
7.56% | 8.13% | 7.41% | 7.43% | |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.56% | 0.35% | 0.44% | 0.61% | |
Graham Net Nets |
(0.14) | (0.16) | (0.17) | (0.12) | |
Graham Number |
65.80 | 65.15 | 62.26 | 51.88 | |
Earnings Yield |
7.97% | 8.68% | 7.05% | 3.92% | |
Free Cash Flow Yield |
9.57% | 11.48% | 11.03% | 6.57% | |
Revenue per Share |
16.74 | 16.11 | 17.38 | 19.03 | |
Operating CF per Share |
4.08 | 2.39 | 1.48 | 1.45 | |
Capex per Share |
(0.69) | (1.31) | (0.87) | (0.74) | |
Free Cash Flow per Share |
3.39 | 1.08 | 0.62 | 0.72 | |
Cash per Share |
4.80 | 4.36 | 4.85 | 4.85 | |
Shareholders Equity per Share |
31.75 | 32.81 | 32.44 | 33.60 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
31.75 | 32.81 | 32.44 | 33.60 | |
Free Cash Flow |
182.00 | 57.00 | 32.00 | 37.00 | |
Working Capital |
582.00 | 583.00 | 479.00 | 530.00 | |
Capital Expenditures |
(37.00) | (69.00) | (45.00) | (38.00) | |
Net Current Asset Value |
(571.00) | (571.00) | (663.00) | (576.00) | |
EV/EBIT |
7.98 | 7.38 | 8.83 | 11.58 | |
Capex to Sales |
0.04 | 0.08 | 0.05 | 0.04 | |
Price to Operating Income |
6.58 | 5.87 | 6.97 | 9.51 | |
| Other line items | |||||
Average Receivables |
702.00 | 646.50 | 698.00 | 710.00 | |
Average Payables |
662.00 | 587.00 | 587.50 | 633.00 | |
Average Inventory |
528.00 | 519.50 | 531.50 | 548.50 | |
Average Assets |
3,775.50 | 3,699.50 | 3,840.50 | 3,906.00 | |
Average Common Equity |
1,647.50 | 1,622.00 | 1,638.50 | 1,708.50 |
Columns are period end dates